Effect of random seed placement error in permanent transperineal prostate seed implant

Radiotherapy and Oncology

Volumn 79, Issue 1, 2006, Pages 70-74

  Bues, Martin ^a   Holupka, Edward J ^b,c   Meskell, Paul ^b   Kaplan, Irving D ^b,c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Prostate cancer; Random seed placement error; Seed implant

Indexed keywords

IODINE 125;

ARTICLE; BRACHYTHERAPY; CONTROLLED STUDY; DOSIMETRY; HUMAN; MALE; NORMAL DISTRIBUTION; ORGAN SIZE; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIOACTIVITY; SATISFACTION; STOCHASTIC MODEL; THERAPEUTIC ERROR; TRANSPERINEAL PROSTATE SEED IMPLANT; TREATMENT PLANNING; URETHRA;

BRACHYTHERAPY; EVALUATION STUDIES; HUMANS; IODINE RADIOISOTOPES; MALE; MEDICAL ERRORS; PROSTATE; PROSTATIC NEOPLASMS; RADIATION DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, COMPUTER-ASSISTED;

EID: 33646197029     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.02.001     Document Type: Article

References (18)

1. Al-Qaisieh B. Pre- and post-implant dosimetry: an inter-comparison between UK prostate brachytherapy centres. Radiother Oncol 66 (2003) 181-183
2. Battermann J., Boon T., and Moerland M. Results of permanent prostate brachytherapy, 13 years of experience at a single institution. Radiother Oncol 71 (2004) 23-28
3. Beaulieu L., Archambault L., Aubin S., Oral E., Taschereau R., and Pouliot J. The robustness of dose distributions to displacement and migration of I permanent seed implants over a wide range of seed number, activity and designs. Int J Radiat Oncol Biol Phys 58 (2004) 1298-1308
4. Blasko J.C., Ragde H., and Schumacher D. Transperineal percutaneous iodine-125 implantation for prostatic carcinoma using tranrectal ultrasound and template guidance. Endocurietherapy/Hyperthermia Oncol 3 (1987) 131-139
5. Dawson J.E., Wu T., Roy T., Gu J.Y., and Kim H. Dose effects of seeds placement deviations from pre-planned positions in ultrasound guided prostate implants. Radiother Oncol 32 (1994) 268-270
6. Kang S., Chou R., Dodge R., et al. Acute urinary toxicity following transperineal prostate brachytherapy using a modified Quimby loading method. Int J Radiat Oncol Biol Phys 50 (2001) 937-945
7. Mangili P., Stea L., Cattani F., et al. Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes. Radiother Oncol 71 (2004) 13-21
8. Matzkin H., Kaver I., Bramante-Schreiber L., et al. Comparison between two iodine-125 brachytherapy implant techniques: pre-planning and intra-operative by various dosimetry quality indicators. Radiother Oncol 68 (2003) 189-194
9. McElveen T., Waterman F., Hayeon K., and Dicker A. Factors predicting for urinary incontinence after prostate brachytherapy. Int J Radiat Oncol Biol Phys 59 (2004) 1395-1404
10. Nath R., Anderson L.L., Luxton G., et al. Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Committee Task Group no. 43. Med Phys 22 (1995) 209-234
11. Potters L., Cao Y., Calugaru E., et al. A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 50 (2001) 605-614
12. Potters L., Klein E., Kattan M., et al. Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation. Radiother Oncol 71 (2004) 29-33
13. Wallner K., Roy J., and Harrison L. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys 32 (1995) 465-471
14. Willins J., and Wallner K. CT-based doismetry for transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys 39 (1997) 347-353
15. Wust P., von Borczyskowski D., Henkel T., et al. Clinical and physical determinants for toxicity of 125-I seed prostate brachytherapy. Radiother Oncol 73 (2004) 39-48
16. Wuu C.-S., Ennis R.D., Schiff P.B., Lee E.K., and Zaider M. Dosimetric and volumetric criteria for selecting a source activity and a source type (I or Pd) in the presence of irregular seed placement in permanent prostate implants. Int J Radiat Oncol Biol Phys 47 (2000) 815-820
17. Yu Y., Waterman F.M., Suntharalingam N., and Schulsinger A. Limitations of the minimum peripheral dose as a parameter for dose specification in permanent 125I prostate implants. Int J Radiat Oncol Biol Phys 34 (1996) 717-725
18. Zelefsky M.J., Wallner K.E., Ling C.C., et al. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J Clin Oncol 17 (1999) 517-522